Can This Beaten-Down AI Stock Bounce Back in 2026?

It might take a while for this AI company to prove its worth, if it ever does so.

Designing the future of metabolic health through tissue-selective drug delivery

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...
The Malaysian Reserve

AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift

Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary – The global AI medical ...
FierceBiotech

Fierce Biotech Layoff Tracker 2026: Bitterroot backtracks; IO implements deep cuts

Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...